Description
BSE Demat Auction No. 831 listing securities subject to auction settlement on 04/03/2026, covering 97 scrips across various sectors.
Summary
BSE has issued Demat Auction Notice No. 831 for settlement dated 04/03/2026. This auction covers 97 scrip codes where delivery obligations were not fulfilled through normal settlement, requiring auction settlement to protect buyers.
Key Points
- Auction Settlement No. 831 dated 04/03/2026
- Total of 97 scrips listed for demat auction
- Quantities range from 1 share (e.g., ALEMBIC PHARMA, HDFC BANK) to 217,789 shares (Sylph Industries)
- Large quantity auctions include: Sylph Industries (217,789), EVEXIA LIFECARE (83,932), Viram Suvarn (14,744), AMPVOLTS LIM (3,646)
- Covers equities across banking, pharma, auto, energy, IT, FMCG and other sectors
Regulatory Changes
No new regulatory changes. This is a routine operational auction notice under existing BSE settlement regulations.
Compliance Requirements
- Member brokers with short delivery positions in the listed scrips must participate in or comply with the auction settlement process
- Buyers whose deliveries were short must be compensated through auction settlement or close-out as per BSE rules
- Clearing members must ensure settlement of auction obligations by the stipulated date
Important Dates
- Auction Settlement Date: 04/03/2026
- Settlement No.: 831
Impact Assessment
This is a routine demat auction notice with moderate operational impact. The auction affects buyers and sellers in 97 scrips where normal delivery failed. Most quantities are small (1–500 shares), though a few scrips (Sylph Industries at 217,789 shares, EVEXIA LIFECARE at 83,932 shares) have significant auction quantities that could influence their prices on auction day. Affected brokers and clearing members must act promptly to settle obligations.
Impact Justification
Routine demat auction notice affecting 97 scrips; operationally significant for member brokers and clearing participants but not a market-wide regulatory change.